Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. - Wikidata - wikimedia - TriplyDB

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

http://www.wikidata.org/entity/Q33249354

about

Intravitreal steroids for macular edema in diabetes BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema Clinical development of new treatments for diabetic macular oedema Pathophysiology of diabetic retinopathy A review of therapies for diabetic macular oedema and rationale for combination therapy Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial.Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series Clinical trials on corticosteroids for diabetic macular edema Pharmacotherapies for diabetic retinopathy: present and future.Emerging pharmacotherapies for diabetic macular edema.A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.Emerging drugs for diabetic retinopathy.Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.Pharmacologic therapies for diabetic retinopathy and diabetic macular edema Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Cost-effectiveness of treatment of diabetic macular edema.Current treatments for radiation retinopathy.Novel Pharmacologic Approaches for the Management of Diabetic Retinopathy Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial.Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation Diabetic retinopathy (treatment)Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema.Using skew-symmetric mixed models for investigating the effect of different diabetic macular edema treatments by analyzing central macular thickness and visual acuity responses Review of therapeutic advances in diabetic retinopathy.Pathophysiology and treatment of diabetic retinopathy.Current treatments in diabetic macular oedema: systematic review and meta-analysis Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.Comparison of intravitreal bevacizumab with macular photocoagulation for treatment of diabetic macular edema: a systemic review and Meta-analysis.Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema.Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema Diabetic retinopathy - An update.Ocular complications of diabetes mellitus.Evolving strategies in the management of diabetic retinopathy Comparative effectiveness of intravitreal bevacizumab with or without triamcinolone acetonide for treatment of diabetic macular edema.A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe.

P2860

Q24242456-A7288C4F-9982-49C2-B1F0-E0C170367A79 Q24644700-806E61B7-DD42-438F-9F5F-F45973D7CDC7 Q26775853-C75EC34E-E676-4461-A42E-521D08A79443 Q26786012-426478B0-D342-470C-91C5-0C265A271404 Q26825365-B6584F37-E2C7-47A4-9056-B6EC0BC737F8 Q26865897-82EDAE14-8542-4C28-AB67-37E0CCC69AE4 Q27008325-0A454231-E4B3-4D97-9BCD-F9431C6A33DE Q30863562-D6D95210-4043-42F0-92F5-1D81FF5842F6 Q31095625-F273A97F-B5D5-4DA7-8600-8B55B225B72F Q31146864-750AFA46-AF74-4920-B344-7CDA43421B6A Q33294882-5456E091-B36D-4081-AA6B-DA7C556AF197 Q33304852-B4F581E6-9331-4248-8913-8225FA51472D Q33355710-358B1860-E56A-4B0E-BDC4-3B8C67303185 Q33388498-EDB06BA3-14C9-4860-B5F4-959892D27C42 Q33431322-AA90F94A-4B7F-48B0-BD6B-1C9D835A7EC3 Q33492340-AA9A00B5-4972-49D6-93C1-380674EE58D8 Q33546338-A6757785-3CB8-4EFE-AA71-2925518C5BA6 Q33567438-160DC4F4-8967-4DC6-9E00-8BC14EA860D5 Q33606611-4B2AE248-DEBA-4C37-85DB-DABD14D146C2 Q33665180-AF7A7531-A8BF-4F1C-8830-3F416CBF9CDD Q33751308-48F0BCDD-22F3-44DF-BAD4-E70A06CB0C95 Q33795925-CE672D4B-8FC7-4B9A-A4F4-80CD346A1389 Q33843242-5F4F37D2-86A4-41A4-9F44-551F6FE564A6 Q33910631-60B96638-D339-4837-8C1A-1C9DF8AD9B2F Q34037627-CED7BC22-A14B-4489-AD0C-EC3E3E13F12A Q34413638-047B2B58-AEC8-46DD-8252-54EA83A82C28 Q34475449-7385C1C7-C9B4-4E41-A0DA-636ED1140D75 Q34528134-F0F96A55-3194-42AB-96E7-8A109F00F48A Q34606190-EA9868F5-2369-4F95-BDB8-27C4388D2CA9 Q34705556-6DCE775D-F38C-4C7E-81C2-2B1BFFD8CDC8 Q34735711-5409D9DD-94AD-4ABD-9162-60DC9ADACE23 Q34758061-7E79A8D3-54D5-49C0-BAEE-0E5755031218 Q34942261-994B753F-3D61-4BD4-865C-677EA333AB30 Q34957902-631EA696-5F41-4A86-B5B7-932A401E18E9 Q35049903-00A4DD9D-DF6D-41F1-8515-B4562EF36478 Q35067102-ED828231-F9B9-4FFC-9710-2717285953B8 Q35549467-059F1872-C70E-41F1-AA12-1467BC497752 Q35592903-8387CF0B-7EBF-41AC-92DE-CC7A792BD050 Q35594036-4299A40E-0EBE-489E-BCD1-C0CE5A76A2DA Q35618569-41F6B3C6-6178-4345-A2AE-9091893D2356

P2860

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

http://www.wikidata.org/entity/Q33249354

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Intravitreal triamcinolone for ...... ed, randomized clinical trial.

@ast

Intravitreal triamcinolone for ...... ed, randomized clinical trial.

@en

type

label

Intravitreal triamcinolone for ...... ed, randomized clinical trial.

@ast

Intravitreal triamcinolone for ...... ed, randomized clinical trial.

@en

prefLabel

Intravitreal triamcinolone for ...... ed, randomized clinical trial.

@ast

Intravitreal triamcinolone for ...... ed, randomized clinical trial.

@en

P1433

Q33249354-55BEFC0E-383C-44BA-993E-110081D0E6F3

P1476

Q33249354-03907BCA-BF69-470D-BAAE-2DC38F0F9398

P2093

Q33249354-52EE629E-9982-4472-B623-5CC323194E18

Q33249354-7A7F2FD4-A3F5-4A70-84AC-5F9EDC53998E

Q33249354-B512C577-7F51-47C1-AD7F-20523FEF149F

Q33249354-D5230434-5203-4F1D-8DBB-F925B4C5B043

Q33249354-D5BCB95D-44F9-43B9-8572-9260E813FC7C

P304

Q33249354-B6D4A9BC-2AA7-4EBB-BC64-A9A54CFDDF1B

P31

Q33249354-11ED00C1-2367-49C8-B359-007B6D862757

P356

Q33249354-33AE4421-EBA1-400E-9E2B-9F22959C2650

P433

Q33249354-1905D832-3C54-471F-850A-149CDF8421CD

P478

Q33249354-C43470F8-4D71-4F21-9B96-01CD1A75BA82

P50

Q33249354-AE7C4E8C-D8F8-46D1-B78E-E1EEB175DFFD

P577

Q33249354-24DA357C-0CEB-4CFF-972C-9C6FFBDB09BC

P5875

Q33249354-42C30B74-B644-4FEE-B29A-C9DCF40B058A

P698

Q33249354-45D15323-36DC-4168-9D7D-AC71806FE860

P921

Q33249354-85D2DF06-46EC-4F53-9D1E-A6ABECF1C53B

P356

J.OPHTHA.2006.02.065

P1433

P1476

Intravitreal triamcinolone for ...... ed, randomized clinical trial.

@en

P2093

Florian K P Sutter

http://www.w3.org/2001/XMLSchema#string

Haipha Ali

http://www.w3.org/2001/XMLSchema#string

Jorgen Larsson

http://www.w3.org/2001/XMLSchema#string

Mark C Gillies

http://www.w3.org/2001/XMLSchema#string

Meidong Zhu

http://www.w3.org/2001/XMLSchema#string

P304

1533-1538

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2006.02.065

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6955940

http://www.w3.org/2001/XMLSchema#string

P698

16828501

http://www.w3.org/2001/XMLSchema#string

P921